We examined CMT1A duplication of 17p11.2-p12, mutations of PMP22, MPZ (P0), GJB1 (Cx32), EGR2 and NEFL genes in 57 Korean families with patients diagnosed as having Charcot-Marie-Tooth (CMT) disease. The CMT1A duplication was present in 53.6% of 28 CMT type 1 patients. In the 42 CMT families without
Mutational analysis of PMP22, GJB1 and MPZ in Greek Charcot–Marie–Tooth type 1 neuropathy patients
✍ Scribed by G Karadima; P Floroskufi; G Koutsis; D Vassilopoulos; M Panas
- Book ID
- 110889252
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 492 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0009-9163
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In the original published version of this article, the authors misdesignated a GJB1 mutation. The c.408T>C (p.Val136Ala) mutation should be written to c.407T>C (p.Val136Ala
Charcot-Marie-Tooth disease (CMT) is a clinically and genetically heterogeneous disorder of the peripheral nervous system. CMT type 1 is most frequently caused by a 1.4 Mb tandem duplication in chromosome 17p11.2 comprising the peripheral myelin protein 22 (PMP22) gene. Furthermore sequence variatio
## Communicated by Mark Paalman Charcot-Marie-Tooth disease (CMT) and related inherited peripheral neuropathies, including Dejerine-Sottas syndrome, congenital hypomyelination, and hereditary neuropathy with liability to pressure palsies (HNPP), are caused by mutations in three myelin genes: PMP22,